|
|
|
|
| LEADER |
01862naa a2200409 i 4500 |
| 001 |
NSK01001063405 |
| 003 |
HR-ZaNSK |
| 005 |
20200520102320.0 |
| 007 |
ta |
| 008 |
200520s2017 ci | |0|| ||hrv |
| 035 |
|
|
|a (HR-ZaNSK)001063405
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a hrv
|b eng
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 615
|2 2011
|
| 080 |
1 |
|
|a 616
|2 2011
|
| 100 |
1 |
|
|a Krečak, Ivan
|4 aut
|
| 245 |
1 |
0 |
|a Fludarabin, ciklofosfamid i rituksimab (FCR) u liječenju bolesnika s kroničnom limfocitnom leukemijom (KLL) :
|b iskustvo Kliničkoga bolničkog centra Zagreb = Fludarabine, cyclophosphamide and rituximab (FCR) in the treatment of chronic lymphocytic leukemia (CLL) : University Hospital Centre Zagreb experience /
|c Ivan Krečak, Sandra Bašić-Kinda, Dino Dujmović, Ida Hude, Ivo Radman-Livaja, Klara Dubravčić, Koraljka Gjadrov Kuveždić, Ivana Ilić, Igor Aurer.
|
| 246 |
3 |
1 |
|a Fludarabine, cyclophosphamide and rituximab (FCR) in the treatment of chronic lymphocytic leukemia (CLL) :
|b University Hospital Centre Zagreb experience
|
| 504 |
|
|
|a Bibliografija: 40 jed.
|
| 504 |
|
|
|a Summary
|
| 653 |
|
0 |
|a Kronična limfocitna leukemija
|a Farmakoterapija
|a Fludarabin
|a Ciklofosfamid
|a Rituksimab
|
| 653 |
|
2 |
|a Klinički bolnički centar Zagreb
|
| 653 |
|
5 |
|a Hrvatska
|
| 700 |
1 |
|
|a Bašić-Kinda, Sandra
|4 aut
|
| 700 |
1 |
|
|a Dujmović, Dino
|4 aut
|
| 700 |
1 |
|
|a Hude, Ida
|4 aut
|
| 700 |
1 |
|
|a Radman Livaja, Ivan
|4 aut
|
| 700 |
1 |
|
|a Dubravčić, Klara
|4 aut
|
| 700 |
1 |
|
|a Gjadrov Kuveždić, Koraljka
|4 aut
|
| 700 |
1 |
|
|a Ilić, Ivana,
|c patologinja
|4 aut
|
| 700 |
1 |
|
|a Aurer, Igor
|4 aut
|
| 773 |
0 |
|
|t Liječnički vjesnik
|x 0024-3477
|g 139 (2017), 7/8 ; str. 210-215
|w nsk.(HR-ZaNSK)000005727
|
| 981 |
|
|
|b B12/17
|
| 998 |
|
|
|b gtao2005
|
| 856 |
4 |
1 |
|u https://hrcak.srce.hr/189762
|y Elektronička verzija članka
|